Which statement about MG is true?

Prepare for the OPSA Essentials Exam with tailored flashcards and multiple-choice questions, each packed with helpful hints and detailed explanations. Get ready to succeed and ace your exam!

Multiple Choice

Which statement about MG is true?

Explanation:
Fatigable weakness that worsens with use and improves with rest is a hallmark of myasthenia gravis, an autoimmune disorder of the neuromuscular junction. In MG, antibodies (often against acetylcholine receptors or related proteins) reduce the safety margin of transmission at the neuromuscular junction, so muscle response declines with repeated use and with higher temperatures. This makes weakness fluctuate and be accentuated by activity and heat, which is why this statement is true. Spinal muscular atrophy, by contrast, involves progressive motor neuron loss leading to steadily worsening proximal weakness rather than weakness that waxes and wanes with exertion. Motor neuron disease (ALS) mixes upper and lower motor neuron signs and isn’t characterized by isolated diastolic hypertension. Hypertension isn’t a defining feature of MG, either.

Fatigable weakness that worsens with use and improves with rest is a hallmark of myasthenia gravis, an autoimmune disorder of the neuromuscular junction. In MG, antibodies (often against acetylcholine receptors or related proteins) reduce the safety margin of transmission at the neuromuscular junction, so muscle response declines with repeated use and with higher temperatures. This makes weakness fluctuate and be accentuated by activity and heat, which is why this statement is true.

Spinal muscular atrophy, by contrast, involves progressive motor neuron loss leading to steadily worsening proximal weakness rather than weakness that waxes and wanes with exertion. Motor neuron disease (ALS) mixes upper and lower motor neuron signs and isn’t characterized by isolated diastolic hypertension. Hypertension isn’t a defining feature of MG, either.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy